Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

IMAX Prices $220M 0.75% Convertible Notes Due 2030 To Refinance 2026 Notes And Strengthen Balance Sheet

Author: Benzinga Newsdesk | November 04, 2025 01:59am
  • Opportunistic capital raise for the substantial refinancing of outstanding 2026 notes
  • IMAX to purchase capped calls intended to offset any share dilution until a 75% premium to the last reported sale price of IMAX's common shares on the date of pricing

Posted In: IMAX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist